Risk factors for development of systemic lupus erythematosus: Allergies, infections, and family history

Journal of Clinical Epidemiology

Volumn 55, Issue 10, 2002, Pages 982-989

  Cooper, Glinda S ^a   Dooley, Mary Anne ^b   Treadwell, Edward L ^c   St Clair, E William ^d   Gilkeson, Gary S ^e  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Autoimmune disease; Herpes zoster; Infections; Sulfa drug; Systemic lupus erythematosus

Indexed keywords

ANTIBIOTIC AGENT; CODEINE; HEPATITIS B VACCINE; PENICILLIN G; SULFANILAMIDE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRIVER LICENCE; DRUG HYPERSENSITIVITY; EPSTEIN BARR VIRUS; FAMILY HISTORY; FEMALE; HEPATITIS B; HERPES ZOSTER; HUMAN; IMPLANT; INFECTION; INFECTIOUS MONONUCLEOSIS; MALE; PARENT; PRIORITY JOURNAL; RISK FACTOR; SIBLING; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; DRUG HYPERSENSITIVITY; FEMALE; HERPESVIRIDAE INFECTIONS; HUMANS; HYPERSENSITIVITY; INFECTION; INFLUENZA, HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK FACTORS; TUBERCULOSIS;

EID: 0036819216     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(02)00429-8     Document Type: Article

References (35)

1. Mills J.A. Systemic lupus erythematosus. N Engl J Med. 330:1994;1871-1879.
2. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M.H. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 84:1997;223-243.
3. Cooper G.S., Dooley M.A., Treadwell E.L., St Clair E.W., Parks C.G., Gilkeson G.S. Hormonal, environmental, and infectious disease risk factors for the development of systemic lupus erythematosus. Arthritis Rheum. 41:1998;1714-1724.
4. Walsh S.J., Rau L.M. Autoimmune diseases. a leading cause of death among young and middle-aged women in the United States Am J Public Health. 90:2000;1463-1466.
5. Kono D.H., Burlingame R.W., Owens D.G.et al. Lupus susceptibility loci in New-Zealand mice. Proc Natl Acad Sci USA. 91:1994;10168-10172.
6. Cooper G.S., Miller F.W., Pandey J.P. The role of genetic factors in autoimmune disease. implications for environmental research Environ Health Perspect. 107(Suppl 5):1999;693-700.
7. Deapen D., Escalante A., Weinrib L.et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 35:1992;311-318.
8. Strom B.L., Reidenberg M.M., West S., Snyder E.S., Freundlich B., Stolley P.D. Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol. 140:1994;632-642.
9. Petri M., Allbritton J. Antibiotic allergy in systemic lupus erythematosus. a case-control study J Rheumatol. 19:1992;265-269.
10. James J.A., Kaufman K.M., Farris A.D., Taylor-Albert E., Lehman T.J.A., Harley J.B. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest. 100:1997;3019-3026.
11. Maillerfert J.F., Sibilia J., Toussirot E.et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology. 38:1999;989-993.
12. Tan E.M., Cohen A.S., Fries J.F.et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1982;1271-1277.
13. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:1997;1725.
14. Morton S., Palmer B., Muir K., Powell R.J. IgE and non-IgE mediated allergic disorders in systemic lupus erythematosus. Ann Rheum Dis. 57:1998;660-663.
15. Albert L.J., Inman R.D. Molecular mimicry and autoimmunity. N Engl J Med. 341:1999;2068-2074.
16. Gilkeson G.S., Pippen A.M.M., Pisetsky D.S. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest. 95:1995;1398-1402.
17. Sabbatini A., Bombardieri S., Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol. 23:1993;1146-1152.
18. Crowcroft N.S., Vyse A., Brown D.W.G., Strachan D.P. Epidemiology of Epstein-Barr virus infection in pre-adolescent children. application of a new salivary method in Edinburgh Scotland J Epidemiol Community Health. 52:1998;101-104.
19. Vyse A.J., Gay N.J., Slomka M.J.et al. The burden of infection with HSV-1 and HSV-2 in England and Wales. implications for the changing epidemiology of genital herpes Sex Trans Infect. 76:2000;183-187.
20. Kangro H.O., Osman H.K., Lan Y.L., Heath R.B., Yeung C.Y., Ng M.H. Seroprevalence of antibodies to human herpes viruses in England and Hong Kong. J Med Virol. 43:1994;91-96.
21. Hernán M.A., Zhang S.M., Lipworth L., Olek M.J., Ascherio A. Multiple sclerosis and age at infection with common viruses. Epidemiology. 12:2001;301-306.
22. Symmons D.P.M., Bankhead C.R., Harrison B.J.et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis. Arthritis Rheum. 40:1997;1955-1961.
23. Nelson J.L. Maternal-fetal immunology and autoimmune disease. Is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum. 39:1996;191-194.
24. Nagata C., Fujita S., Iwata H.et al. Systemic lupus erythematosus. a case-control epidemiologic study in Japan Int J Dermatol. 34:1995;333-337.
25. Lawrence J.S., Martins C.L., Drake G.L. A family survey of lupus erythematosus. 1. Heritability J Rheumatol. 14:1987;913-921.
26. th edition. New Providence, NJ: Marquis Who's Who; 1995.
27. Ward M.M., Studenski S. Systemic lupus erythematosus in men. a multivariate analysis of gender differences in clinical manifestations J Rheumatol. 17:1990;220-224.
28. Calvo-Alén J., Bastian H.M., Straaton K.V., Burgard S.L., Mikhail I.S., Alarcón G.S. Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum. 38:1995;1475-1484.
29. Molina J.F., Molina J., García C., Gharavi A.E., Wilson W.A., Espinoza L.R. Ethnic differences in the clinical expression of systemic lupus erythematosus. a comparative study between African-Americans and Latin Americans Lupus. 6:1997;63-67.
30. Linet M.S., Harlow S.D., McLaughlin J.K., McCaffrey L.D. A comparison of interview data and medical records for previous medical conditions and surgery. J Clin Epidemiol. 42:1989;1207-1213.
31. Salkind A.R., Cuddy P.G., Foxworth J.W. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA. 285:2001;2498-2505.
32. Sogn D.D., Evans R. III, Shepherd G.M.et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med. 152:1992;1025-1032.
33. Schmader K., George L.K., Newton R., Hamilton J.D. The accuracy of self-report of herpes zoster. J Clin Epidemiol. 47:1994;1271-1276.
34. Confavreux C., Suissa S., Saddier P., Bourdes V., Vukusic S., for the Vaccines in Multiple Sclerosis Study Group Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med. 344:2001;319-326.
35. Schmader K., George L.K., Burchett B.M., Hamilton J.D., Pieper C.F. Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc. 46:1998;973-977.